Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 10, 2001
Potential risks and prevention, Part 3: Drug-induced threats to lifeK Marcellino, W N KellyFaculty Reviews|April 5, 2021
Recent advances in prognostication and treatment of polycythemia veraBridget K Marcellino, Ronald HoffmanAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 27, 2001
Potential risks and prevention, Part 1: Fatal adverse drug eventsW N KellyAmerican Journal of Hospital Pharmacy|September 1, 1986
Strategic planning for clinical services: Hamot Medical CenterW N KellyAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 27, 2001
Potential risks and prevention, Part 2: Drug-induced permanent disabilitiesW N KellyPharmacotherapy|May 15, 2001
Can the frequency and risks of fatal adverse drug events be determined?W N KellyAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 10, 2001
Potential risks and prevention, Part 4: Reports of significant adverse drug eventsW N KellyClinical Lymphoma, Myeloma & Leukemia|March 23, 2020
The Myelodepletive Phenotype in Myelofibrosis: Clinical Relevance and Therapeutic ImplicationBridget K Marcellino, Srdan Verstovsek, John MascarenhasClinical Advances in Hematology & Oncology : H&O|August 19, 2021
Alternatives to intensive treatment in patients with AMLGracie Himmelstein, John Mascarenhas, Bridget K MarcellinoClinical Advances in Hematology & Oncology : H&O|July 8, 2022
JAK inhibitors in the treatment of myelofibrosisHannah Levavi, Ronald Hoffman, Bridget K MarcellinoPageof 6